An Open Trial of Cysteamine Treatment in Schizophrenia
Status:
Terminated
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the tolerability of the medication cysteamine
bitartrate on schizophrenia patients and to evaluate the effect of the medication on the
symptoms of schizophrenia.